Search Results for: opaganib

A “super cork” for Covid

Researchers at Israel’s Weizmann Institute have developed a small molecule that stops the coronavirus spike protein from attaching to the lungs’ ACE2 receptor. But it doesn’t damage ACE2’s normal function. (See also here for similarities with opaganib from Israel’s Redhill). … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Protection against Delta variant

A pre-clinical trial of opaganib from Israel’s Redhill (see here previously) shows that its strong antiviral and anti-inflammatory activities can inhibit any variant of the SARS-Cov-2 virus. Opaganib targets SK2 – a key enzyme used by the virus to replicate, … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

No entry for coronavirus

Israel’s Redhill has completed its Phase 2 / 3 clinical trials of its opaganib treatment on 475 coronavirus patients in Israel, Europe and Brazil. In a few weeks it will declare the results. Opaganib works on the patient rather than … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Positive results for Covid-19 treatment

Preliminary data from Phase 2 trials of opaganib from Israel’s Redhill (reported here previously) on 40 hospitalized Covid-19 patients showed positive results. Patients receiving opaganib had significantly reduced dependence on ventilators and faster time to discharge. https://www.prnewswire.com/il/news-releases/redhill-s-phase-2-3-covid-19-candidate-opaganib-reduces-ards-related-blood-clotting-in-preclinical-model-813822864.html

Posted in Israel's Medical Achievements | Leave a comment

Pennsylvania grant for Covid-19 therapy

The US State of Pennsylvania has given a grant of $300,000 to help advance the clinical testing of opaganib from Israel’s RedHill Biopharma (reported here previously). The grant is part of the state’s program supporting the rapid advancement of promising … Continue reading

Posted in Economy & Business | Leave a comment

Israeli coronavirus treatment benefits six patients

Six moderate to severe Israeli coronavirus patients have shown clinical improvement with the new opaganib  treatment from Israel’s Redhill (see here previously). All required less supplemental oxygenation, had higher lymphocyte counts and less lung inflammation. https://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=2432&PID=0&IID=15261

Posted in Israel's Medical Achievements | Leave a comment

Another potential coronavirus treatment

Israeli biotech Redhill has announced that another of its pipeline medicines RHB-107 (upamostat) is to be tested by the US National Institute of Allergy and Infectious Diseases (NIAID) against SARS-CoV2, the virus that causes COVID-19. (Redhill’s Opaganib is already saving … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Italy approves Israeli coronavirus treatment

Italy has approved Opaganib from Israel’s Redhill Biopharma to treat some 160 severe COVID-19 patients with severe respiratory problems at three hospitals in northern Italy. Phase2 tests on 131 US patients were positive and two critically ill Israeli patients are … Continue reading

Posted in Israel's Medical Achievements | Leave a comment